EXAGEN INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $66.6 | $55.6 | $52.5 | $45.6 | $48.3 |
| Operating income | -$14.1 | -$13.6 | -$22.8 | -$46.1 | -$24.1 |
| Net income | -$20.0 | -$15.1 | -$23.7 | -$47.4 | -$26.9 |
| Cash Flow Statement | |||||
| Free cash flow | -$14.3 | -$13.8 | -$15.3 | -$36.5 | -$22.6 |
| Share repurchases | — | — | — | — | $12.8 |
Shares outstanding 24.2M · Free float 62.8%
Annual filing data through FY ended December 31, 2025; float as of September 26, 2026.
Exagen Raises 2026 Revenue Outlook After Record Quarter